Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation (Q33403568)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation |
scientific article |
Statements
1 reference
Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillation (English)
1 reference
John A Butera
1 reference
Bjarne Due Larsen
1 reference
James K Hennan
1 reference
Edward Kerns
1 reference
Li Di
1 reference
Asaf Alimardanov
1 reference
Robert E Swillo
1 reference
Gwen A Morgan
1 reference
Kun Liu
1 reference
Qiang Wang
1 reference
Eric I Rossman
1 reference
Rayomand Unwalla
1 reference
Leonard McDonald
1 reference
Christine Huselton
1 reference
Jørgen S Petersen
1 reference
1 February 2009
1 reference
1 reference
52
1 reference
908-911
1 reference
Identifiers
1 reference
1 reference